Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis

CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission

Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra

Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase

GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase

Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines

Starton Therapeutics Inc a clinicalstage biotechnology company transforming standardofcare therapies with proprietary dermal technologies announced today the successful completion of enrollment for its STARLLD Phase b clinical trial

Parexel one of the worlds largest clinical research organizations providing the full range of Phase I to IV clinical development services and Palantir Technologies Inc a leading builder of Artificial Intelligence systems today announced a multiyear

Arrowhead Pharmaceuticals Inc announced today that it has dosed the first subjects in a Phase a clinical trial of AROCFB the companys investigational RNA interference therapeutic in up to healthy volunteers and patients with complement

BioAffinity Technologies Inc a biotechnology company focused on the need for noninvasive accurate tests for the detection of earlystage lung cancer and other lung diseases today announced David Elzi PhD has been named Vice President